1. Modeling Molecular Pathogenesis of Idiopathic Pulmonary Fibrosis-Associated Lung Cancer in Mice
   Ivana Barravecchia et al, 2024, Molecular Cancer Research CrossRef
2. New Perspectives on Myeloid-Derived Suppressor Cells and Their Emerging Role in Haematology
   Nikoleta Bizymi et al, 2022, Journal of Clinical Medicine CrossRef
3. CD40 DNA hypermethylation in primary gastric tumors; as a novel diagnostic biomarker
   Mohammad Amini et al, 2020, Life Sciences CrossRef
4. Oxaliplatin regulates myeloid‐derived suppressor cell‐mediated immunosuppression via downregulation of nuclear factor‐κB signaling
   Na‐Rae Kim et al, 2019, Cancer Medicine CrossRef
5. CD45+CD33lowCD11bdim myeloid-derived suppressor cells suppress CD8+ T cell activity via the IL-6/IL-8-arginase I axis in human gastric cancer
   Fang-yuan Mao et al, 2018, Cell Death & Disease CrossRef
6. Harnessing the potential of CD40 agonism in cancer therapy
   Yang Zhou et al, 2024, Cytokine & Growth Factor Reviews CrossRef
7. CD40 controls CXCR5-induced recruitment of myeloid-derived suppressor cells to gastric cancer
   Yixin Ding et al, 2015, Oncotarget CrossRef
8. Phenotypically resembling myeloid derived suppressor cells are increased in children with HIV and exposed/infected with Mycobacterium tuberculosis
   Nelita Du Plessis et al, 2017, European Journal of Immunology CrossRef
9. Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
   Andrew M. K. Law et al, 2020, Cells CrossRef
10. Mechanistic basis of co-stimulatory CD40-CD40L ligation mediated regulation of immune responses in cancer and autoimmune disorders
    Tikam Chand Dakal et al, 2020, Immunobiology CrossRef
11. Arsenic trioxide inhibits tumor-induced myeloid-derived suppressor cells and enhances T-cell activity
    Qingmin Gao et al, 2017, Oncology Letters CrossRef
12. Montanide, Poly I:C and nanoparticle based vaccines promote differential suppressor and effector cell expansion: a study of induction of CD8 T cells to a minimal Plasmodium berghei epitope
    Kirsty L. Wilson et al, 2015, Frontiers in Microbiology CrossRef
13. Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial
    Evanthia.T. Roussos Torres et al, 2024, Nature Cancer CrossRef